University Of Vermont
Clinical trials sponsored by University Of Vermont, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New study tests smartphone app to fight chemo nerve damage Results expected Sep 2026 (estimated)
- New 'Think in nerve Length' technique could ease tennis elbow pain Results expected Nov 2026 (estimated)
- Could a menopause drug cool hot flashes in men with prostate cancer? Results expected Jan 2027 (estimated)
- Cash for clinic visits: new study tests financial incentives to keep opioid patients in treatment Results expected Apr 2027 (estimated)
- Free meals delivered to homes of people in opioid recovery Results expected Jul 2027 (estimated)
-
Doctors inject chemo directly into lung tumors in early trial
Disease control OngoingThis early-phase trial tests a new method to deliver the chemotherapy drug cisplatin directly into lung tumors using a bronchoscope. The goal is to find the safest dose and see if this approach can help control stage IV lung cancer. Only 16 participants are enrolled, and the main…
Phase 1 • Sponsor: University of Vermont • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Could a common steroid make AML treatment easier to tolerate?
Disease control By invitation onlyThis early-phase study tests whether adding the steroid dexamethasone to standard low-intensity chemotherapy is safe and tolerable for adults newly diagnosed with acute myeloid leukemia (AML) who cannot have intensive chemo. About 20 participants will receive the combination over…
Phase 1 • Sponsor: University of Vermont • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Thinking about the future might help smokers kick the habit, but study never got off the ground
Knowledge-focused CancelledThis study planned to test whether asking daily smokers to imagine positive future events could reduce their desire to smoke and make them more cautious about losses. The researchers intended to enroll adults who smoked at least five cigarettes a day and measure their smoking beh…
Sponsor: University of Vermont • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New program aims to stop blood clots in cancer patients
Knowledge-focused By invitation onlyThis study tests a modified clinical program to help doctors better prevent blood clots (VTE) in cancer patients starting treatment. About 25 patients and their doctors will take part. The program includes education for doctors and a structured risk assessment to decide if blood-…
Sponsor: University of Vermont • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC